Is the Current Treatment of Schizophrenia the best we can do?

preview_player
Показать описание
Michael Davidson MD, CMO of Minerva Neurosciences Inc.

Lecture about the current treatment of schizophrenia, the negative symptoms and the new MIN-101 compound.

European Conference of Psychiatry and Mental Health “Galatia 2018”, Galati, Romania
Рекомендации по теме